Bank Hapoalim BM Buys Shares of 89,200 Teladoc Health, Inc. $TDOC

Key Points

• Bank Hapoalim BM acquired a new stake in Teladoc Health, purchasing 89,200 shares valued at approximately $777,000 in the second quarter, bringing its ownership to 0.05% of the company.
• According to recent earnings reports, Teladoc Health posted an EPS of ($0.19), beating estimates, with revenue of $631.90 million, though it showed a 1.6% year-over-year decline.
• The company has received mixed analyst ratings, with a consensus hold rating and a price target averaging $9.80, reflecting uncertainty in its stock performance.

Bank Hapoalim BM bought a new stake in Teladoc Health, Inc. (NYSE:TDOC - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 89,200 shares of the health services provider's stock, valued at approximately $777,000. Bank Hapoalim BM owned approximately 0.05% of Teladoc Health as of its most recent SEC filing.

Other large investors also recently added to or reduced their stakes in the company. Golden State Wealth Management LLC grew its holdings in Teladoc Health by 102.6% in the 1st quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider's stock valued at $27,000 after buying an additional 1,690 shares in the last quarter. National Bank of Canada FI grew its holdings in shares of Teladoc Health by 79.4% during the 1st quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider's stock worth $28,000 after purchasing an additional 1,581 shares during the period. SVB Wealth LLC purchased a new position in shares of Teladoc Health during the 1st quarter worth $37,000. BI Asset Management Fondsmaeglerselskab A S purchased a new position in shares of Teladoc Health during the 1st quarter worth $50,000. Finally, Ameritas Advisory Services LLC purchased a new position in shares of Teladoc Health during the 2nd quarter worth $78,000. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

TDOC opened at $9.01 on Friday. The stock's 50-day moving average price is $7.66 and its 200 day moving average price is $7.60. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21. The company has a current ratio of 2.67, a quick ratio of 2.58 and a debt-to-equity ratio of 0.70. The firm has a market cap of $1.59 billion, a price-to-earnings ratio of -7.57 and a beta of 1.90.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.27) by $0.08. Teladoc Health had a negative return on equity of 10.13% and a negative net margin of 8.16%.The firm had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same quarter in the prior year, the company earned ($0.38) EPS. Teladoc Health's revenue was down 1.6% on a year-over-year basis. Teladoc Health has set its Q3 2025 guidance at -0.350--0.200 EPS. FY 2025 guidance at -1.350--1.000 EPS. As a group, sell-side analysts expect that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Analyst Ratings Changes

TDOC has been the subject of a number of research analyst reports. Mizuho initiated coverage on Teladoc Health in a report on Friday, July 25th. They set a "neutral" rating and a $10.00 price target for the company. Weiss Ratings reiterated a "sell (d-)" rating on shares of Teladoc Health in a report on Saturday, September 27th. Finally, Evercore ISI increased their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an "in-line" rating in a report on Wednesday, July 9th. Six research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has given a Sell rating to the company's stock. According to MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $9.80.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.